Cellectar Biosciences (CLRB) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

CLRB is expected to report earnings to fall 3.91% to -30 cents per share on November 12

Cellectar Biosciences CLRB Stock Earnings Reports

Q3'24

Est.

$-0.31

Q2'24

Missed

by $0.02

Q1'24

Missed

by $0.21

Q4'23

Missed

by $2.58

Q3'23

Missed

by $0.64

The last earnings report on August 13 showed earnings per share of -31 cents, missing the estimate of -30 cents. With 256.66K shares outstanding, the current market capitalization sits at 73.13M.

View a ticker or compare two or three

Compare

CLRB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CLRB
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

100 Campus Drive

Phone

+1 608 441-8120

Employees

Web

https://www.cellectar.com